china
Celgene Buys The Rights To BeiGene’s Checkpoint Inhibitor
BeiGene will acquire Celgene's commercial operations in China and exclusive license to Celgene's China cancer commercial portfolio.
BGI Genomics’ IPO Raises US$250 Million
BGI Genomics’ President Wang Jian says the capital raised through the initial public offering will be used to help the company dominate the genomics market.
Beating Dengue Is In Your DNA (Vaccine)
A DNA-based vaccine against dengue, which would not require cold chain transport, has been shown to protect mice against two out of the four strains of dengue virus.
Giving Bacteria An Electrifying ‘Armor’
Coating bacteria in a conductive polymer not only increases the efficiency of electron transfer but also helps them survive better in microbial fuel cells.
Making Memories With Mitochondrial Flashes
Mitochondrial flashes in the brain help convert short-term memories into long-term ones.
Training AI To Spot Lung Cancer
An artificial neural network trained to recognize cancerous nodules could help detect lung cancers earlier and improve patient survival.
iCarbonX Joins HealthLoop’s US$8.4 Million Series B Round
The participation of iCarbonX brings the total Series B investment in HealthLoop’s patient-engagement platform to US$8.4 million.
7 Must-Read Stories In June 2017
Climate change, solar energy and disease were key issues in the month of June.
Mammals Use RNA Interference Too
Like plants and invertebrates, mammalian cells also use RNA interference to protect themselves against viral infections.
